Top

Pediatric Radiology

Published in:

01-06-2006 | Original Article

F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas

Authors: Miguel Hernandez-Pampaloni, Amol Takalkar, Jian Q. Yu, Hongming Zhuang, Abass Alavi

Published in: Pediatric Radiology | Issue 6/2006

Abstract

Background

We hypothesized that F-18 FDG-PET could be a useful, functional imaging modality for assessing the initial staging, response to therapy and follow-up of children diagnosed with lymphoma.

Objective

To assess the role of whole-body F-18 FDG-PET imaging in patients with lymphoma as an initial staging modality and to measure its predictive value for monitoring the response to therapy and disease recurrence compared to CT and clinical follow-up studies.

Materials and methods

As part of their routine clinical care, 24 patients with histologically proven lymphoma (18 Hodgkin disease and 6 non-Hodgkin lymphoma) underwent an F-18 FDG-PET and a CT scan. A total of 28 studies were performed and the entire set of scans retrospectively reviewed. Seven studies were performed for initial staging, 12 for monitoring therapy response and 9 for detecting recurrence. Initial diagnosis was confirmed by histopathology while the gold standard at follow-up was established by clinical follow-up, additional imaging modalities and/or biopsy. F-18 FDG-PET was visually compared to CT on a lesion-by-lesion basis. Fifteen anatomic regions (seven nodal and eight extranodal) were analyzed.

Results

Of the 414 regions analyzed, PET and CT were concordant in 366 (positive in 16 and negative in 350). Discordance was found in 48 regions. Overall sensitivities, specificities, and positive and negative predictive values were 78%, 98%, 94% and 90% for F-18 FDG-PET and 79%, 88%, 90% and 46% for CT, respectively.

Conclusion

F-18 FDG-PET imaging is a useful technique for the staging and follow-up of pediatric patients with lymphoma.

Magnani C, Gatta G, Coriazzari I, et al (2001) Childhood malignancies in the EUROCARE study: the database and the methods of survival analysis. Eur J Cancer 37:678–686PubMedCrossRef

Hudson MM, Donaldson SS (1997) Hodgkin’s disease. Pediatr Clin North Am 44:891–906PubMedCrossRef

Sandlund JT, Downing JR, Crist WM (1996) Non-Hodgkin’s lymphoma in childhood. N Engl J Med 334:1238–1248PubMedCrossRef

Edwards BK, Brown ML, Wingo PA, et al (2005) Annual report to the nation on the status of cancer, 1975–2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97:1407–1427PubMedCrossRef

Brousse N, Vasiliu V, Michon J (2004) Pediatric non-Hodgkin lymphomas. Ann Pathol 24:574–586PubMedCrossRef

Thomson AB, Wallace WH (2002) Treatment of paediatric Hodgkin’s disease: a balance of risks. Eur J Cancer 38:468–477PubMedCrossRef

Pinkerton CR (1999) The continuing challenge of treatment for non-Hodgkin’s lymphoma in children. Br J Haematol 107:220–234PubMedCrossRef

Reske SN (2003) PET and restaging of malignant lymphoma including residual masses and relapse. Eur J Nucl Med Mol Imaging 30:S89–S96PubMed

Schiepers C, Filmont FE, Czernin J (2003) PET for staging of Hodgkin’s disease and non-Hodgkin’s lymphoma. Eur J Nucl Med Mol Imaging 30:S82–S88PubMed

10.

Schoder H, Larson SM, Yeung HW (2004) PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies. J Nucl Med 45:72S–81SPubMed

11.

Kumar R, Xiu Y, Potenta S, et al (2004) 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas. J Nucl Med 45:1796–1803PubMed

12.

Elstrom R, Guan L, Baker G, et al (2003) Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 101:3875–3876PubMedCrossRef

13.

Depas G, De Barsy C, Jerusalem G, et al (2005) 18F-FDG PET in children with lymphomas. Eur J Nucl Med Mol Imaging 32:31–38PubMedCrossRef

14.

Hermann S, Wormanns D, Pixberg M, et al (2005) Staging in childhood lymphoma: differences between FDG-PET and CT. Nuklearmedizin 44:1–7PubMed

15.

Munker R, Glass J, Griffeth LK, et al (2004) Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin’s disease. Ann Oncol 15:1699–1704PubMedCrossRef

16.

Zinzani PL, Fanti S, Battista G, et al (2004) Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. Br J Cancer 91:850–854PubMed

17.

Brenot-Rossi I, Bouabdallah R, Di Stefano D, et al (2001) Hodgkin’s disease: prognostic role of gallium scintigraphy after chemotherapy. Eur J Nucl Med 28:1482–1488PubMedCrossRef

18.

Front D, Bar-Shalom R, Mor M, et al (2000) Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphy. Radiology 214:253–257PubMed

19.

Rini JN, Nunez R, Nichols R, et al (2005) Coincidence-detection FDG-PET versus gallium in children and young adults with newly diagnosed Hodgkin’s disease. Pediatr Radiol 35:169–178PubMedCrossRef

20.

Kaste SC, Howard SC, McCarville EB, et al (2005) 18F-FDG-avid sites mimicking active disease in pediatric Hodgkin’s. Pediatr Radiol 35:141–154PubMedCrossRef

21.

Weinblatt ME, Zanzi I, Belakhlef A, et al (1997) False-positive FDG-PET imaging of the thymus of a child with Hodgkin’s disease. J Nucl Med 38:888–890PubMed

22.

Bangerter M, Moog F, Buchmann I, et al (1998) Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin’s disease. Ann Oncol 9:1117–1122PubMedCrossRef

23.

Wickmann L, Luders H, Dorffel W (2003) 18-FDG-PET-findings in children and adolescents with Hodgkin’s disease: retrospective evaluation of the correlation to other imaging procedures in initial staging and to the predictive value of follow-up examinations. Klin Padiatr 215:146–150PubMedCrossRef

24.

Pinkerton R (2005) Continuing challenges in childhood non-Hodgkin’s lymphoma. Br J Haematol 130:480–488PubMedCrossRef

25.

Weihrauch MR, Re D, Scheidhauer K, et al (2001) Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease. Blood 98:2930–2934PubMedCrossRef

26.

Montravers F, McNamara D, Landman-Parker J, et al (2002) [(18)F]FDG in childhood lymphoma: clinical utility and impact on management. Eur J Nucl Med Mol Imaging 29:1155–1165PubMedCrossRef

27.

Kostakoglu L, Goldsmith SJ (2000) Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears? Eur J Nucl Med 27:1564–1578PubMedCrossRef

28.

Moog F, Bangerter M, Diederichs CG, et al (1998) Extranodal malignant lymphoma: detection with FDG PET versus CT. Radiology 206:475–481PubMed

29.

Spaepen K, Stroobants S, Dupont P, et al (2001) Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin’s disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity? Br J Haematol 115:272–278PubMedCrossRef

Title: F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas
Authors: Miguel Hernandez-Pampaloni
Amol Takalkar
Jian Q. Yu
Hongming Zhuang
Abass Alavi
Publication date: 01-06-2006
Publisher: Springer-Verlag
Published in: Pediatric Radiology / Issue 6/2006
Print ISSN: 0301-0449
Electronic ISSN: 1432-1998
DOI: https://doi.org/10.1007/s00247-006-0152-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas

Abstract

Background

Objective

Materials and methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Objective

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2006

Comparison of lingual tonsil size as depicted on MR imaging between children with obstructive sleep apnea despite previous tonsillectomy and adenoidectomy and normal controls

A guide to the recognition of skeletal disorders in the fetus

Cyst-like cortical tubers in patients with tuberous sclerosis complex: MR imaging with the FLAIR sequence

Visceral heterotaxia with polysplenia syndrome and haemorrhagic splenic infarction as a rare cause of the acute paediatric abdomen

Hermes

Supernumerary umbilical vein demonstrated by radiography of a 27-week-gestation neonate